en
E-mail us

Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.

The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
Speaker: Margaret Offermann, M.D., Ph.D. (CEO, OncoSpherix)
Repurposing Dexmedetomidine into an Oral Sleep-Enhancing Medication
Repurposing Dexmedetomidine into an Oral Sleep-Enhancing Medication
Speaker: Oluwaseun Johnson‐Akeju, M.D., MMSc; (Professor of Anesthesiology: Massachusetts General Hospital and Harvard Medical School)
The Purpose Behind Molecules to Medicine
The Purpose Behind Molecules to Medicine
Speakers: Robert Wenslow, Ph.D. (Head US Operations, Crystal Pharmatech), Yongqiang Li, Ph.D. (CEO, Candoo Pharmatech), Joe Armstrong, Ph.D. (COO, TCG Green Chem), Chris Senanayake, Ph.D. (CEO/CSO, TCG Green Chem)
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303